These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 15006313

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Progress in contraception: new technology.
    Linn ES.
    Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
    Creasy GW, Fisher AC, Hall N, Shangold GA.
    J Reprod Med; 2003 Mar; 48(3):179-86. PubMed ID: 12698776
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
    Merz M, Kroll R, Lynen R, Bangerter K.
    Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. New hormonal contraceptives: a comprehensive review of the literature.
    Forinash AB, Evans SL.
    Pharmacotherapy; 2003 Dec; 23(12):1573-91. PubMed ID: 14695038
    [Abstract] [Full Text] [Related]

  • 30. Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study.
    Dittrich R, Parker L, Rosen JB, Shangold G, Creasy GW, Fisher AC, Ortho Evra/Evra 001 Study Group.
    Am J Obstet Gynecol; 2002 Jan; 186(1):15-20. PubMed ID: 11810078
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
    Lopez LM, Grimes DA, Gallo MF, Stockton LL, Schulz KF.
    Cochrane Database Syst Rev; 2013 Apr 30; 2013(4):CD003552. PubMed ID: 23633314
    [Abstract] [Full Text] [Related]

  • 34. Evra contraceptive patch: risks of thromboembolism.
    Prescrire Int; 2007 Jun 30; 16(89):113-4. PubMed ID: 17590909
    [No Abstract] [Full Text] [Related]

  • 35. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
    Harel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D.
    J Pediatr Adolesc Gynecol; 2005 Apr 30; 18(2):85-90. PubMed ID: 15897103
    [Abstract] [Full Text] [Related]

  • 36. [Transdermal contraception--a new beginning].
    Sigridov I, Dikov I, Ivanov S.
    Akush Ginekol (Sofiia); 2004 Apr 30; 43 Suppl 1():19-27. PubMed ID: 15323313
    [No Abstract] [Full Text] [Related]

  • 37. The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
    Wooltorton E.
    CMAJ; 2006 Jan 17; 174(2):164-5. PubMed ID: 16368722
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
    Devineni D, Skee D, Vaccaro N, Massarella J, Janssens L, LaGuardia KD, Leung AT.
    J Clin Pharmacol; 2007 Apr 17; 47(4):497-509. PubMed ID: 17389559
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Transdermal contraception methods: today's patches and new options on the horizon.
    Nelson AL.
    Expert Opin Pharmacother; 2015 Apr 17; 16(6):863-73. PubMed ID: 25800084
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.